長期投資家のためのIR情報
バリュートレンド

【2664】カワチ薬品
ドラッグストア。栃木地盤。

売上高
営業利益
経常利益
当期利益
{{models[key].tabname}}
決算期 日付 予・実 売上高
(百万円)
対前回 修正率 修正率 営業利益
(百万円)
対前回 修正率 修正率 経常利益
(百万円)
対前回 修正率 修正率 当期利益
(百万円)
対前回 修正率 修正率
2027.03 2026/07/29 Q1予 285,000 → 0.0% 0.0% 5,100 → 0.0% 0.0% 6,000 → 0.0% 0.0% 3,000 → 0.0% 0.0%
2027.03 2026/04/28 当初予 285,000 - - - 5,100 - - - 6,000 - - - 3,000 - - -
2026.03 2026/04/28 実 284,492 ↓ -0.9% -2.6% 6,779 ↑ +13.0% -13.1% 7,897 ↑ +12.8% -9.2% 3,200 ↓ -13.5% -34.7%
2026.03 2026/01/27 Q3予 287,000 → 0.0% -1.7% 6,000 → 0.0% -23.1% 7,000 → 0.0% -19.5% 3,700 → 0.0% -24.5%
2026.03 2025/10/29 Q2予 287,000 ↓ -1.7% -1.7% 6,000 ↓ -23.1% -23.1% 7,000 ↓ -19.5% -19.5% 3,700 ↓ -24.5% -24.5%
2026.03 2025/07/24 Q1予 292,000 → 0.0% 0.0% 7,800 → 0.0% 0.0% 8,700 → 0.0% 0.0% 4,900 → 0.0% 0.0%
2026.03 2025/04/24 当初予 292,000 - - - 7,800 - - - 8,700 - - - 4,900 - - -
2025.03 2025/04/24 実 287,816 ↓ -0.4% -1.4% 7,461 ↓ -4.3% -6.7% 8,340 ↓ -4.1% -7.3% 4,884 ↓ -9.6% -14.3%
2025.03 2025/01/23 Q3予 289,000 → 0.0% -1.0% 7,800 → 0.0% -2.5% 8,700 → 0.0% -3.3% 5,400 → 0.0% -5.3%
2025.03 2024/10/25 Q2予 289,000 ↓ -1.0% -1.0% 7,800 ↓ -2.5% -2.5% 8,700 ↓ -3.3% -3.3% 5,400 ↓ -5.3% -5.3%
2025.03 2024/07/26 Q1予 292,000 → 0.0% 0.0% 8,000 → 0.0% 0.0% 9,000 → 0.0% 0.0% 5,700 → 0.0% 0.0%
2025.03 2024/04/26 当初予 292,000 - - - 8,000 - - - 9,000 - - - 5,700 - - -
2024.03 2024/04/26 実 285,960 ↓ -0.2% -0.2% 7,601 ↑ +8.6% +26.7% 8,609 ↑ +7.6% +23.0% 4,713 ↓ -1.8% +12.2%
2024.03 2024/01/25 Q3予 286,500 → 0.0% 0.0% 7,000 → 0.0% +16.7% 8,000 → 0.0% +14.3% 4,800 → 0.0% +14.3%
2024.03 2023/10/26 Q2予 286,500 → 0.0% 0.0% 7,000 ↑ +16.7% +16.7% 8,000 ↑ +14.3% +14.3% 4,800 ↑ +14.3% +14.3%
2024.03 2023/07/26 Q1予 286,500 → 0.0% 0.0% 6,000 → 0.0% 0.0% 7,000 → 0.0% 0.0% 4,200 → 0.0% 0.0%
2024.03 2023/04/28 当初予 286,500 - - - 6,000 - - - 7,000 - - - 4,200 - - -
2023.03 2023/04/28 実 281,871 ↑ +0.7% -0.4% 6,611 ↓ -5.6% -19.4% 7,672 ↓ -5.3% -16.6% 4,177 ↓ -9.2% -24.1%
2023.03 2023/01/26 Q3予 280,000 → 0.0% -1.1% 7,000 → 0.0% -14.6% 8,100 → 0.0% -12.0% 4,600 → 0.0% -16.4%
2023.03 2022/10/26 Q2予 280,000 ↓ -1.1% -1.1% 7,000 ↓ -14.6% -14.6% 8,100 ↓ -12.0% -12.0% 4,600 ↓ -16.4% -16.4%
2023.03 2022/07/28 Q1予 283,000 → 0.0% 0.0% 8,200 → 0.0% 0.0% 9,200 → 0.0% 0.0% 5,500 → 0.0% 0.0%
2023.03 2022/04/27 当初予 283,000 - - - 8,200 - - - 9,200 - - - 5,500 - - -
2022.03 2022/04/27 実 279,462 ↓ -0.9% -0.9% 7,709 ↓ -3.6% +2.8% 8,698 ↓ -3.4% +2.3% 4,830 ↓ -16.7% -12.2%
2022.03 2022/01/27 Q3予 282,000 → 0.0% 0.0% 8,000 → 0.0% +6.7% 9,000 → 0.0% +5.9% 5,800 → 0.0% +5.5%
2022.03 2021/10/26 Q2予 282,000 → 0.0% 0.0% 8,000 ↑ +6.7% +6.7% 9,000 ↑ +5.9% +5.9% 5,800 ↑ +5.5% +5.5%
2022.03 2021/07/27 Q1予 282,000 → 0.0% 0.0% 7,500 → 0.0% 0.0% 8,500 → 0.0% 0.0% 5,500 → 0.0% 0.0%
2022.03 2021/04/26 当初予 282,000 - - - 7,500 - - - 8,500 - - - 5,500 - - -
2021.03 2021/04/26 実 284,492 ↑ +0.9% +5.4% 10,560 ↑ +11.2% +111.2% 11,581 ↑ +10.3% +93.0% 7,109 ↑ +9.4% +77.7%
2021.03 2021/01/22 Q3予 282,000 ↑ +0.7% +4.4% 9,500 ↑ +11.8% +90.0% 10,500 ↑ +10.5% +75.0% 6,500 ↑ +12.1% +62.5%
2021.03 2020/10/23 Q2予 280,000 ↑ +1.1% +3.7% 8,500 ↑ +21.4% +70.0% 9,500 ↑ +18.8% +58.3% 5,800 ↑ +20.8% +45.0%
2021.03 2020/07/22 Q1予 277,000 ↑ +2.6% +2.6% 7,000 ↑ +40.0% +40.0% 8,000 ↑ +33.3% +33.3% 4,800 ↑ +20.0% +20.0%
2021.03 2020/04/24 当初予 270,000 - - - 5,000 - - - 6,000 - - - 4,000 - - -
2020.03 2020/04/24 実 270,313 ↑ +1.2% +1.2% 5,675 ↑ +18.2% +18.2% 6,573 ↑ +11.4% +2.7% 3,822 ↑ +3.3% -6.8%
2020.03 2020/01/24 Q3予 267,000 → 0.0% 0.0% 4,800 → 0.0% 0.0% 5,900 → 0.0% -7.8% 3,700 → 0.0% -9.8%
2020.03 2019/10/25 Q2予 267,000 → 0.0% 0.0% 4,800 → 0.0% 0.0% 5,900 ↓ -7.8% -7.8% 3,700 ↓ -9.8% -9.8%
2020.03 2019/07/24 Q1予 267,000 → 0.0% 0.0% 4,800 → 0.0% 0.0% 6,400 → 0.0% 0.0% 4,100 → 0.0% 0.0%
2020.03 2019/04/25 当初予 267,000 - - - 4,800 - - - 6,400 - - - 4,100 - - -
2019.03 2019/04/25 実 264,926 ↓ -1.0% -2.6% 3,886 ↓ -7.5% -22.3% 5,517 ↓ -6.5% -15.1% 2,016 ↓ -42.4% -49.6%
2019.03 2019/01/23 Q3予 267,500 → 0.0% -1.7% 4,200 → 0.0% -16.0% 5,900 → 0.0% -9.2% 3,500 → 0.0% -12.5%
2019.03 2018/10/25 Q2予 267,500 ↓ -1.7% -1.7% 4,200 ↓ -16.0% -16.0% 5,900 ↓ -9.2% -9.2% 3,500 ↓ -12.5% -12.5%
2019.03 2018/07/26 Q1予 272,000 → 0.0% 0.0% 5,000 - - - 6,500 → 0.0% 0.0% 4,000 → 0.0% 0.0%
2019.03 2018/04/26 当初予 272,000 - - - - - - - 6,500 - - - 4,000 - - -
2018.03 2018/04/26 実 - - - - - - - - - - - - - - - -
2018.03 2018/01/24 Q3予 272,500 → 0.0% -0.9% 6,000 → 0.0% -7.7% 7,400 → 0.0% -5.1% 4,500 → 0.0% -4.3%
2018.03 2017/10/25 Q2予 272,500 ↓ -0.9% -0.9% 6,000 ↓ -7.7% -7.7% 7,400 ↓ -5.1% -5.1% 4,500 ↓ -4.3% -4.3%
2018.03 2017/07/26 Q1予 275,000 → 0.0% 0.0% 6,500 → 0.0% 0.0% 7,800 → 0.0% 0.0% 4,700 → 0.0% 0.0%
2018.03 2017/04/27 当初予 275,000 - - - 6,500 - - - 7,800 - - - 4,700 - - -
2017.03 2017/04/27 実 266,423 ↓ -0.4% -1.7% 5,723 ↑ +4.1% +4.1% 7,062 ↑ +7.0% +7.0% 3,510 ↓ -12.3% -12.3%
2017.03 2017/01/25 Q3予 267,500 → 0.0% -1.3% 5,500 → 0.0% 0.0% 6,600 → 0.0% 0.0% 4,000 → 0.0% 0.0%
2017.03 2016/10/27 Q2予 267,500 ↓ -1.3% -1.3% 5,500 → 0.0% 0.0% 6,600 → 0.0% 0.0% 4,000 → 0.0% 0.0%
2017.03 2016/04/27 当初予 271,000 - - - 5,500 - - - 6,600 - - - 4,000 - - -
2016.03 2016/04/27 実 260,624 ↓ -0.9% -2.0% 4,656 ↑ +5.8% +16.4% 5,875 ↑ +6.8% +17.5% 1,975 ↓ -29.5% -21.0%
2016.03 2016/01/27 Q3予 263,000 → 0.0% -1.1% 4,400 → 0.0% +10.0% 5,500 → 0.0% +10.0% 2,800 → 0.0% +12.0%
2016.03 2015/10/27 Q2予 263,000 ↓ -1.1% -1.1% 4,400 ↑ +10.0% +10.0% 5,500 ↑ +10.0% +10.0% 2,800 ↑ +12.0% +12.0%
2016.03 2015/07/24 Q1予 266,000 → 0.0% 0.0% 4,000 → 0.0% 0.0% 5,000 → 0.0% 0.0% 2,500 → 0.0% 0.0%
2016.03 2015/04/27 当初予 266,000 - - - 4,000 - - - 5,000 - - - 2,500 - - -
2015.03 2015/04/27 実 258,319 ↓ -4.0% -7.7% 2,814 ↓ -33.0% -66.1% 3,786 ↓ -27.2% -59.3% -4,673 ↓ -8.7% -188.2%
2015.03 2015/01/27 Q3予 269,000 → 0.0% -3.9% 4,200 → 0.0% -49.4% 5,200 → 0.0% -44.1% -4,300 → 0.0% -181.1%
2015.03 2014/10/28 Q2予 269,000 ↓ -3.9% -3.9% 4,200 ↓ -49.4% -49.4% 5,200 ↓ -44.1% -44.1% -4,300 ↓ -181.1% -181.1%
2015.03 2014/07/29 Q1予 280,000 → 0.0% 0.0% 8,300 → 0.0% 0.0% 9,300 → 0.0% 0.0% 5,300 → 0.0% 0.0%
2015.03 2014/04/30 当初予 280,000 - - - 8,300 - - - 9,300 - - - 5,300 - - -
2014.03 2014/04/30 実 242,684 - - - 7,180 - - - 8,054 - - - 2,015 - - -
シェア ツイート
ページトップへ戻る